Evidence map›Paper›PMID 39636051›Full record

ArticleBJPsych open2024

Risk of admission to hospital for self-harm after admission to hospital for COVID-19: French nationwide longitudinal study.

Philippe Pirard, Valentina Decio, Baptiste Pignon, Olivier Bouaziz, Vittorio Perduca, Viviane Kovess-Masfety, Emmanuelle Corruble, Francis Chin, Pierre A Geoffroy, Yann Le Strat and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJPsych open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Philippe PirardNon Communicable Diseases and Trauma Division, Santé publique France, Paris, France.
Valentina DecioNon Communicable Diseases and Trauma Division, Santé publique France, Paris, France.
Baptiste PignonDépartement Médico Universitaire (DMU) - Innovation en santé Mentale, Psychiatrie et AddiCTologie, Hôpitaux Universitaires « H. Mondor », Assistance Publique hôpitaux de Paris (AP-HP), Université Paris-Est-Créteil (UPEC), Mondor Biomedical Research Institute (IMRB - Inserm), Translational Neuropsychiatry, Fondation FondaMental, Créteil, France.ORCID https://orcid.org/0000-0003-0526-3136
Olivier BouazizUniversité Paris Cité, CNRS, MAP5, Paris, France.
Vittorio PerducaUniversité Paris Cité, CNRS, MAP5, Paris, France.
Viviane Kovess-MasfetyNon Communicable Diseases and Trauma Division, Santé publique France, Paris, France; and Laboratoire de Psychopathologie et Processus de Santé, Université Paris Cité, Paris, France.
Emmanuelle CorrubleCESP, MOODS Team, INSERM UMR 1018, Faculté de Médecine, Université Paris-Saclay, Paris, France; and Service Hospitalo-Universitaire de Psychiatrie de Bicêtre, Hôpitaux Universitaires Paris-Saclay, AP-HP, Hôpital de Bicêtre, Paris, France.
Francis ChinData Science Division, Santé publique France, Paris, France.
Pierre A GeoffroyDépartement de Psychiatrie et d'Addictologie, AP-HP, Centre ChronoS, Groupe Hospitalier Universitaire (GHU) Paris Nord, DMU Neurosciences, Hospital Bichat - Claude Bernard, Paris, France; (GHU) Paris - Psychiatry & Neurosciences, Paris, France; and Université de Paris, NeuroDiderot, INSERM, FHU I2-D2, Paris, France.
Yann Le StratData Science Division, Santé publique France, Paris, France.
Jonathan MessikaService de Pneumologie B et Transplantation Pulmonaire, Hôpital Bichat-Claude Bernard, AP-HP, Nord-Université Paris Cité, Paris, France; and Physiopathology and Epidemiology of Respiratory Diseases, UMR1152 INSERM and Université de Paris, Paris, France.
Nolwenn RegnaultNon Communicable Diseases and Trauma Division, Santé publique France, Paris, France.
Sarah TebekaNon Communicable Diseases and Trauma Division, Santé publique France, Paris, France; Department of Psychiatry, AP-HP, Louis Mourier Hospital, Paris, France; and INSERM Team 1 - UMR1266, Institute of Psychiatry and Neurosciences, Université de Paris, Paris, France.ORCID https://orcid.org/0000-0003-0269-4600

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAssessing the risk of subsequent self-harm after hospitalisation for COVID-19 is critical for mental health care planning during and after the pandemic.

aimsThis study aims to compare the risk of admission to hospital for self-harm within 12 months following a COVID-19 hospitalisation during the first half of 2020, with the risk following hospitalisations for other reasons.

methodUsing the French administrative healthcare database, logistic regression models were employed to analyse data from patients admitted to hospitals in metropolitan France between January and June 2020. The analysis included adjustments for sociodemographic factors, psychiatric history and the level of care received during the initial hospital stay.

resultsOf the 96 313 patients hospitalised for COVID-19, 336 (0.35%) were subsequently admitted for self-harm within 12 months, compared to 20 135 (0.72%) of 2 797 775 patients admitted for other reasons. This difference remained significant after adjusting for sociodemographic factors (adjusted odds ratio (aOR) = 0.66, 95% CI: 0.59-0.73), psychiatric disorder history (aOR = 0.65, 95% CI: 0.58-0.73) and the level of care received during the initial hospital stay (aOR = 0.70, 95% CI: 0.63-0.78). History of psychiatric disorders and intensive care were strongly correlated with increased risk, while older age was inversely associated with self-harm admissions.

conclusionsHospitalisation for COVID-19 during the early pandemic was linked to a lower risk of subsequent self-harm than hospitalisation for other reasons. Clinicians should consider psychiatric history and intensive care factors in evaluating the risk of future suicide.

Indexed as

admission to hospitalCOVID-19epidemiologypsychiatric disorderssuicide attempts

Identifiers

PMID39636051
PMCPMC11698173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.